Both in Surgical Instruments
Orchestra BioMed Holdings vs Embecta
Over the past year OBIO returned +47.4% and EMBC returned −54.2%; their daily moves had a correlation of 0.09.
OBIO +47.4% EMBC −54.2%Growth of $1, one year, split-adjusted
| Metric | OBIO | EMBC |
|---|---|---|
| Price | $5.91 | $6.25 |
| Market cap | $355.2M | $354.1M |
| Today | −2.96% | −4.73% |
| 1 month | −6.9% | +7.9% |
| 6 months | +48.9% | −32.3% |
| Year to date | +42.4% | −47.4% |
| 1 year | +63.7% | −54.0% |
| Revenue growth (YoY) | −89.5% | −8.1% |
| Gross margin | 71.6% | 56.4% |
| Net margin | −27362.5% | 7.8% |
| P/E (TTM) | — | 4.0× |
| Price / sales | 11.1× | 0.3× |
| Net cash | $75.1M | -$1.27B |
| Dividend yield | — | 0.64% |
| Volatility (60d) | 63.2% | 73.0% |
| Short % of float | 8.1% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).